Picture of Kainos Laboratories logo

4556 — Kainos Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMicro CapNeutral

Table: Kainos -2022/23 parent results

May 10 (Reuters)- 
          Kainos Laboratories Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           4.92            4.61           5.20          2.60    
               (+6.7 pct)      (+8.4 pct)     (+5.6 pct)    (+3.5 pct) 
  Operating      821 mln         747 mln        850 mln      425 mln   
               (+9.8 pct)      (+18.3 pct)    (+3.5 pct)   (-16.9 pct) 
  Recurring      853 mln         777 mln        850 mln      425 mln   
               (+9.8 pct)      (+19.0 pct)    (-0.5 pct)   (-19.4 pct) 
  Net            568 mln         512 mln        570 mln      285 mln   
               (+10.9 pct)     (+22.7 pct)    (+0.3 pct)   (-20.6 pct) 
  EPS          136.13 yen      126.39 yen     136.56 yen    68.28 yen  
  Ann Div       25.00 yen       25.00 yen      25.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       25.00 yen       25.00 yen      25.00 yen               
  
  NOTE - Kainos Laboratories Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T

Recent news on Kainos Laboratories

See all news